Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries
{{output}}
Background: Managed entry agreements (MEAs) continue to emerge in health technology assessment (HTA)-based decision-making, to address evidentiary uncertainties arising therein. Evidence on the HTA criteria that influence MEAs' u... ...
